Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
A T cell co-stimulation modulator refers to any molecule, typically a receptor or ligand, that influences the secondary signaling required for full T cell activation. These modulators can either enhance (co-stimulatory) or inhibit (co-inhibitory) the primary signal delivered through the T cell receptor (TCR), thereby determining the fate and function of T cells in immune responses. Key examples include CD28 and CD80/CD86 (co-stimulatory) and CTLA-4 and PD-1 (co-inhibitory). Modulation of these pathways has significant therapeutic implications in cancer immunotherapy, autoimmunity, and transplantation.
Modulates T cell activation by influencing the secondary signaling pathways initiated upon T cell receptor (TCR) engagement with peptide-MHC complexes. Can either enhance (co-stimulatory) or inhibit (co-inhibitory) T cell activation.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T cell co-stimulation modulator.